AU5197986A - Transmissible, mammalian genes associated with tumor metastasis - Google Patents

Transmissible, mammalian genes associated with tumor metastasis

Info

Publication number
AU5197986A
AU5197986A AU51979/86A AU5197986A AU5197986A AU 5197986 A AU5197986 A AU 5197986A AU 51979/86 A AU51979/86 A AU 51979/86A AU 5197986 A AU5197986 A AU 5197986A AU 5197986 A AU5197986 A AU 5197986A
Authority
AU
Australia
Prior art keywords
cells
metastasis
dna
tumor
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51979/86A
Other languages
English (en)
Inventor
Shelly C. Bernstein
Robert A. Weinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitehead Institute for Biomedical Research
Original Assignee
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Institute for Biomedical Research filed Critical Whitehead Institute for Biomedical Research
Publication of AU5197986A publication Critical patent/AU5197986A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU51979/86A 1984-11-30 1985-11-26 Transmissible, mammalian genes associated with tumor metastasis Abandoned AU5197986A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67662584A 1984-11-30 1984-11-30
US676625 1991-03-28

Publications (1)

Publication Number Publication Date
AU5197986A true AU5197986A (en) 1986-06-18

Family

ID=24715276

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51979/86A Abandoned AU5197986A (en) 1984-11-30 1985-11-26 Transmissible, mammalian genes associated with tumor metastasis

Country Status (13)

Country Link
EP (1) EP0203970A1 (enExample)
JP (1) JPS62501399A (enExample)
AU (1) AU5197986A (enExample)
DK (1) DK359486D0 (enExample)
ES (1) ES8705043A1 (enExample)
FI (1) FI863095A0 (enExample)
GR (1) GR852864B (enExample)
HU (1) HUT41837A (enExample)
IL (1) IL77157A0 (enExample)
NO (1) NO863066L (enExample)
PT (1) PT81584B (enExample)
WO (1) WO1986003226A1 (enExample)
ZA (1) ZA859070B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
ES2164634T3 (es) * 1989-10-18 2002-03-01 Us Health Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto.
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
DE69630142D1 (de) * 1995-11-16 2003-10-30 Baylor College Medicine Verfahren zur identifizierung metastatischer sequenzen
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
DE69730411T2 (de) * 1996-01-10 2005-09-01 The University Of Liverpool Metastasen induzierende dna's
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
US6252058B1 (en) 1997-11-05 2001-06-26 Timothy C. Thompson Sequences for targeting metastatic cells
EP1062340A2 (en) 1998-03-13 2000-12-27 The Baylor College of Medicine Compositions and methods for the treatment and prevention of metastatic disorders
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Also Published As

Publication number Publication date
EP0203970A1 (en) 1986-12-10
PT81584B (en) 1987-04-07
FI863095A7 (fi) 1986-07-29
DK359486A (da) 1986-07-29
NO863066D0 (no) 1986-07-29
NO863066L (no) 1986-09-29
HUT41837A (en) 1987-05-28
ES8705043A1 (es) 1987-04-16
FI863095L (fi) 1986-07-29
DK359486D0 (da) 1986-07-29
WO1986003226A1 (en) 1986-06-05
GR852864B (enExample) 1986-03-28
FI863095A0 (fi) 1986-07-29
IL77157A0 (en) 1986-04-29
ES549438A0 (es) 1987-04-16
PT81584A (en) 1985-12-01
JPS62501399A (ja) 1987-06-11
ZA859070B (en) 1986-07-30

Similar Documents

Publication Publication Date Title
Mulligan et al. Factors governing the expression of a bacterial gene in mammalian cells
Bernstein et al. Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA.
WO1986003226A1 (en) Transmissible, mammalian genes associated with tumor metastasis
Shih et al. Isolation of a transforming sequence from a human bladder carcinoma cell line
Smithies et al. Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination
EP0518650B1 (en) Sequence specific DNA binding by P53
US5814476A (en) Process for the production of stochastically-generated transcription or translation products
Snyder et al. [7] λgt 11: Gene isolation with antibody probes and other applications
Staal Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.
EP0174810B1 (en) Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein dna
TW212202B (enExample)
EP0346710B1 (en) cDNAs coding for members of the carcinoembryonic antigen family
EP0241961A2 (en) Assay for carcinogenesis caused by oncogenes
Grunwald et al. Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells
Clayton et al. Cloning and characterization of the integrated viral DNA from three lines of SV40-transformed mouse cells
Young et al. Bacteriophage T4 gene transcription studied by hybridization to cloned restriction fragments
US4725550A (en) Novel mutation of the c-K-ras oncogene activated in a human lung carcinoma
Fang et al. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma
US4818694A (en) Production of herpes simplex viral protein
JP3256227B2 (ja) Ｄｎａプローブの開発およびヒト腫瘍関連抗原の免疫学的試薬
Polvino-Bodnar et al. Construction and characterization of viable deletion mutants of simian virus 40 lacking sequences near the 3′ end of the early region
Stanners et al. Cloning of a functional gene responsible for the expression of a cell surface antigen correlated with human chronic lymphocytic leukemia
Fisher et al. Wilms' tumor-aniridia association: segregation of affected chromosome in somatic cell hybrids, identification of cell surface antigen associated with deleted area, and regional mapping of c-Ha-ras-1 oncogene, insulin gene, and beta-globin gene
Ruddle et al. DNA-mediated gene transfer in mammalian gene cloning
Wang et al. Polymerization of vector DNA after transfection into hamster fibroblast cells